Home / News / News & Updates / pCODR Releases Initial Recommendation of Opdivo pCODR Releases Initial Recommendation of Opdivo pCODR releases initial recommendation of Opdivo (nivolumab) for metastatic NSCLC (both squamous and non-squamous); on or after chemotherapy. No test required. This is a great news for NSCLC patients! We hope to see more like this for other types of lung cancer. Read more Initial Recommendation (pdf) News News & Updates Current News November 2023 Newsletter In this issue: LCAM Activities November 2023 Newsletter Read More Lung Cancer Awareness Month: Alberta Health Minister Adriana LaGrange Announcement November is Lung Cancer Awareness Month and my thoughts are with those brave Albertans who are facing this challenging diagnosis. Read More Questions To Ask Clinical Trials Share Your Story Community Activities Make A Donation Peer to Peer Network
Home / News / News & Updates / pCODR Releases Initial Recommendation of Opdivo pCODR Releases Initial Recommendation of Opdivo pCODR releases initial recommendation of Opdivo (nivolumab) for metastatic NSCLC (both squamous and non-squamous); on or after chemotherapy. No test required. This is a great news for NSCLC patients! We hope to see more like this for other types of lung cancer. Read more Initial Recommendation (pdf) News News & Updates Current News November 2023 Newsletter In this issue: LCAM Activities November 2023 Newsletter Read More Lung Cancer Awareness Month: Alberta Health Minister Adriana LaGrange Announcement November is Lung Cancer Awareness Month and my thoughts are with those brave Albertans who are facing this challenging diagnosis. Read More Questions To Ask Clinical Trials Share Your Story Community Activities Make A Donation Peer to Peer Network